Improving lung cancer screening with low-dose CT images and data
LOW-DOSE COMPUTED TOMOGRAPHY IMAGES AND CORRESPONDING DATA
This study is looking to improve lung cancer screening with low-dose CT scans by finding better ways to tell which patients really need more tests after a positive result, so we can reduce unnecessary worry and costs while making sure those who need help get it faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Booz Allen Hamilton NIH-funded |
| Lab location | 1 site (Mc Lean, United States) |
| Project ID | NIH-10724040 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of low-dose computed tomography (LDCT) for lung cancer screening by addressing the high false positive rates associated with the current screening methods. It aims to develop better predictive models to identify which patients with positive LDCT results truly require further diagnostic procedures, such as biopsies. By analyzing data from previous screenings, the research seeks to reduce unnecessary anxiety and healthcare costs while improving timely cancer diagnosis for those who need it. Patients will be involved in the evaluation of new algorithms that could refine screening processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone low-dose CT screening for lung cancer and received positive results.
Not a fit: Patients who have not been screened with low-dose CT or those without any risk factors for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate lung cancer screenings, reducing unnecessary procedures and anxiety for patients.
How similar studies have performed: Previous studies have shown that improving screening methodologies can significantly enhance patient outcomes, indicating potential success for this approach.
Where this research is happening
Mc Lean, United States
- Booz Allen Hamilton — Mc Lean, United States (Active)
Researchers
- Principal investigator: Fernandez, Anna — Booz Allen Hamilton
- Study coordinator: Fernandez, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.